BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32129110)

  • 1. The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field.
    Blanco-Castañeda R; Galaviz-Hernández C; Souto PCS; Lima VV; Giachini FR; Escudero C; Damiano AE; Barragán-Zúñiga LJ; Martínez-Aguilar G; Sosa-Macías M
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):247-263. PubMed ID: 32129110
    [No Abstract]   [Full Text] [Related]  

  • 2. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
    Hakkola J; Pelkonen O; Pasanen M; Raunio H
    Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.
    Prouillac C; Lecoeur S
    Drug Metab Dispos; 2010 Oct; 38(10):1623-35. PubMed ID: 20606001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug transport across the placenta, role of the ABC drug efflux transporters.
    Behravan J; Piquette-Miller M
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):819-30. PubMed ID: 18028027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of drug transporter expression and function in the placenta.
    Staud F; Ceckova M
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):533-55. PubMed ID: 25600150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Barrier role of ABC family of proteins in human placenta].
    Kozłowska-Rup D; Czekaj P
    Ginekol Pol; 2011 Jan; 82(1):56-63. PubMed ID: 21473056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the placenta in drug transport and fetal drug exposure.
    Koren G; Ornoy A
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):373-385. PubMed ID: 29307240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placenta: a human organ for developmental toxicology research and biomonitoring.
    Myllynen P; Pasanen M; Pelkonen O
    Placenta; 2005 May; 26(5):361-71. PubMed ID: 15850640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.
    Myllynen P; Immonen E; Kummu M; Vähäkangas K
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1483-99. PubMed ID: 19785513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.
    Behura SK; Dhakal P; Kelleher AM; Balboula A; Patterson A; Spencer TE
    Pharmacol Res; 2019 Nov; 149():104468. PubMed ID: 31600597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and passive transport of drugs in the human placenta.
    Włoch S; Pałasz A; Kamiński M
    Ginekol Pol; 2009 Oct; 80(10):772-7. PubMed ID: 19943543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate and effects of xenobiotics in human placenta.
    Myllynen P; Pasanen M; Vähäkangas K
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):331-46. PubMed ID: 17539742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transfer and metabolism by the human placenta.
    Syme MR; Paxton JW; Keelan JA
    Clin Pharmacokinet; 2004; 43(8):487-514. PubMed ID: 15170365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental transporters relevant to drug distribution across the maternal-fetal interface.
    Ganapathy V; Prasad PD; Ganapathy ME; Leibach FH
    J Pharmacol Exp Ther; 2000 Aug; 294(2):413-20. PubMed ID: 10900213
    [No Abstract]   [Full Text] [Related]  

  • 15. Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier.
    Giaginis C; Theocharis S; Tsantili-Kakoulidou A
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1263-75. PubMed ID: 22780574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of biliary compounds during intrauterine life.
    Macias RI; Marin JJ; Serrano MA
    World J Gastroenterol; 2009 Feb; 15(7):817-28. PubMed ID: 19230042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model.
    Codaccioni M; Brochot C
    Toxicol Appl Pharmacol; 2020 Dec; 409():115318. PubMed ID: 33160985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapeutic aspects of drug transporters in the placenta].
    Motyl O; Droździk M
    Ginekol Pol; 2016; 87(4):305-9. PubMed ID: 27321104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism.
    Immonen E; Kummu M; Petsalo A; Pihlaja T; Mathiesen L; Nielsen JK; Knudsen LE; Vähäkangas K; Myllynen P
    Placenta; 2010 Jul; 31(7):641-8. PubMed ID: 20570348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy.
    Kammala AK; Lintao RCV; Vora N; Mosebarger A; Khanipov K; Golovko G; Yaklic JL; Peltier MR; Conrads TP; Menon R
    Life Sci; 2022 Oct; 307():120867. PubMed ID: 35940219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.